Recorded device evidence

Overjet Caries Assist (K212519): indications, design and recorded evidence

The acquired K212519 file contains product-specific indications and users, design and operating principle, non-clinical evidence actually described, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 33 selected decisions under primary code MYN. 33 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

Calendar elapsed days: lower quartile 146.0, median 241.0, upper quartile 270.0. These are recorded calendar differences, not active FDA review time.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K212519 ↗ · this pageOverjet Caries Assist2021-08-10 → 2022-05-10273Traditional
K252486 ↗ChestView US (1.1)2025-08-07 → 2026-09-09398Traditional
K261059 ↗Overjet Multi-Image Caries and Charting Assist2026-03-31 → 2026-08-06128Traditional
K260851 ↗Better Diagnostics Dental Assist (BDDA) Version 1.02026-03-16 → 2026-07-15121Traditional
K252953 ↗Velmeni for Dentists (V4D) Endo-Perio2025-09-16 → 2026-05-11237Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K212519 · PDF page 5 ↗ Source 2

The    Overjet    Caries     Assist    (OCA)     is   a   radiological,    automated,      concurrent     read,
              computer-assisted     detection    software   intended    to  aid  in the  detection   and   segmentation     of
              caries  on  bitewing   radiographs.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K212519 · PDF page 4 ↗ Source 3

Overjet   Caries  Assist   (OCA)    is a radiological   automated    concurrent    read  computer-assisted
             detection   (CAD)    software    intended   to  aid in  the  detection   and  segmentation     of  caries  on
             bitewing   radiographs.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Non-clinical evidence actually described

K212519 · PDF page 12 ↗ Source 4

Overjet    Caries  Assist   has  been   verified  and  validated   according    to  Overjet’s   design   control
             processes.     All  supporting     documentation       has   been   included    in   this  510(k)    Premarket
             Notification.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

Performance evidence actually described

K212519 · PDF page 8 ↗ Source 5

Read this statement in the original PDF; no complete statement fits the short excerpt.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {'uncertain_pdf_page': 1}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK212519 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryOverjet Caries Assist [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantOverjet, Inc. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeMYN [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2022-05-10 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2021-08-10 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Non-clinical evidence actually described — what differs in our product?

    Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

    Useful evidence: Existing protocols/results and design-specific evidence gaps, with standard editions and scope reviewed separately.

  4. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[50378] · record 3f863fcb593217e0dc84c3f90035d34ccf42bbfc8651aa73f7ce81da97527449
  • [6] Complete results array / fda-decision-context:K212519 · record whole dataset partition

FDA 510(k) summary — K212519 ↗

Wed, 11 May 2022 20:00:04 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 490b206b2b947c5fcd33954368129106d7d49a87a0468cea58ee259029c49294

  • [2] PDF page 5 · record e30fac8d88712aecf856ca3c423fcbeccb3fc2793e7f8014615f3cd4ac5c631b
  • [3] PDF page 4 · record bb5e5eaa4ab95e544a719fa5f314e76392e3e2871827692539b7c04d021922cb
  • [4] PDF page 12 · record d238326505bb80d0f91351d08ec434b55120f38b94eeeb58a52583df8b73daf4
  • [5] PDF page 8 · record 34db99e262da295088e01ac8caf2166115582d35e303298df4e88df4ee539e8d

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services